Current therapies such as biological DMARDs showed promising results in treating rheumatoid arthritis patients, and market penetration is expected to be more in the future and expected to drive market ...

Rheumatoid arthritis (RA) is a chronic autoimmune condition. The UM Faculty Physicians team is dedicated to helping you ...

New data reinforce rosnilimab’s efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, ...

A new approach targets the B-cell pathway with bispecific antibodies, building on decades of research that establishes the ...

Rheumatoid arthritis treatment aims to reduce inflammation, relieve pain, and preserve joint function through biologics, DMARDs, physical therapy, lifestyle changes, and sometimes surgery. Advances in ...

The new biotech Elevara plans to initiate Phase II testing of its lead candidate ELV001 as an add-on treatment for rheumatoid ...

A study presented at ACR Convergence 2025 has sparked interest among doctors and patients alike. Drugs originally made for ...

Boston, Oct. 08, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Therapies for Rheumatoid Arthritis: Technologies and Global Markets” is projected to increase from $30.2 ...

CHICAGO -- Hitting rheumatoid arthritis (RA) early and hard, with targeted therapies as first-line treatment, appears to ...

Peripheral neuropathy can develop as a complication of rheumatoid arthritis (RA). You may find similar treatments for both, but your doctor is best equipped to determine what medications may work for ...

NEW YORK (Reuters Health) - Three available drugs that belong to the newest class of drugs for treating rheumatoid arthritis -- the tumor necrosis factor (TNF)-alpha blockers -- are equally effective ...

Rheumatoid arthritis (RA) may cause inflammation in your eyes, leading to complications such as dry eyes, redness, and floaters, among others. Early treatment may prevent these conditions from ...